From molecule to dossier: the technical and regulatory capability behind every complex generic we develop.
Fixed dose and multi component formulations requiring aligned pharmacokinetics and joint stability profiles.
Formulation and bioequivalence work for actives where small variance carries clinical consequence.
Release profile engineering including soft gel encapsulation and micronised active formulations.
CTD format submissions built on public domain clinical evidence, bridging studies, and expert synthesis.
Immediate & modified release
Hard shell, dual compartment
Micronised active suspension
Sterile vial & prefilled formats
Topical, dermal application
Topical, sustained delivery
We work with a network of GMP certified contract development and manufacturing organisations across the EU and UK, matched to each formulation’s specific technical requirements.
Our model links specialist development, manufacturing and market execution across the UK and Europe through selected CDMO and supply partners.
Talk to us about licensing, co-development, or distribution.